CommercialCoverageMedium impact
08.00.41c, Teprotumumab-trbw (Tepezza®)
Independence Blue Cross·Endocrinology, Ophthalmology·Pharmacy
Effective date
Oct 1, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has updated their pharmacy policy for Teprotumumab-trbw (Tepezza®), effective October 1, 2025. This is a fresh policy update that may affect coverage criteria, prior authorization requirements, or billing procedures for this thyroid eye disease medication.
Action Required
By October 1, 2025: Review the complete policy details at the provided URL to understand specific changes to Teprotumumab-trbw (Tepezza®) coverage. Update prior authorization workflows and billing procedures as needed based on the full policy content. Notify providers who treat thyroid eye disease patients of any coverage changes.